Skip to main content

$0.095 0.002 (2.15%)

High

$0.10

Low

$0.10

Trades

1

Turnover

$475

Volume

5,000
30 June 2023 at 12:12pm
Register to track ILA and receive email alerts.
Subject
ILA Ann: Updated Investor Presentation & Webinar Invitation

ILA Ann: Change in substantial holding

ILA Ann: Release of Securities from Escrow

ILA Ann: Quarterly Activity Report & Appendix 4C

ILA Ann: Island executes PEACH clinical study CRO agreement

ILA Ann: Change in substantial holding

ILA Ann: Appendix 3Y - Anna Lavelle

ILA Ann: Appendix 3Y - Albert Hansen

ILA Ann: Appendix 3Y - David Brookes

ILA Ann: Cleansing Notice

ILA Ann: Application for quotation of securities - ILA

ILA Ann: Results of Annual General Meeting

ILA Ann: Annual General Meeting MD Presentation

ILA Ann: Annual General Meeting Chair Address

ILA Ann: ISLA-101 Phase 2a clinical trial update

ILA Ann: Quarterly Activity Report & Appendix 4C

ILA Ann: Change in substantial holding

ILA Ann: Proposed issue of securities - ILA

ILA Ann: Annual Report to shareholders

ILA Ann: Letter to Shareholders & Notice of Annual General Meeting

ILA Ann: Change in substantial holding

ILA Ann: Updated Investor Presentation

ILA Ann: Release of Securities from Voluntary Escrow

ILA Ann: Date of AGM & Closing Date for Director Nominations

ILA Ann: Island updates API agreement

ILA Ann: Appendix 4G

ILA Ann: Corporate Governance Statement

ILA Ann: Appendix 4E & Annual Report

ILA Ann: Griffith Uni Anti-Viral Molecule Screening Collaboration

ILA Ann: Change in substantial holding

ILA Ann: Island granted key Australian patent for ISLA-101

ILA Ann: Becoming a substantial holder

ILA Ann: Quarterly Activity Report & Appendix 4C

ILA Ann: Island secures API - shortens timeline to clinical trials

ILA Ann: ASEAN Dengue Day - Investor briefing notification

ILA Ann: Island Pharmaceuticals granted key United States patent

ILA Article: Cancer/virus drug outfit Zucero kicks off IPO roadshow

ILA Article: Dengue fever drug company vaults 124pc on ASX debut

ILA Ann: Island lists on following oversubscribed IPO

ILA Ann: Island Pharmaceuticals IPO Investor Presentation

ILA Ann: Appendix 3X - Anna Lavelle

ILA Ann: Appendix 3X - David Brookes

ILA Ann: Appendix 3X - Paul MacLeman

ILA Ann: Appendix 3X - David Foster

ILA Ann: Appendix 3X - Albert Hansen

ILA Ann: Becoming a substantial holder

ILA Ann: Becoming a substantial holder

ILA Ann: Becoming a substantial holder

ILA Ann: Pre-Quotation Disclosure Statement

ILA Ann: Top 20 Holders

Register to track ILA and receive email alerts.